Yeshanew Solomon, Gete Worke, Chilo Desalegn
Department of Biology, Debre Markos University, Debre Markos, Ethiopia.
Department of Clinical Pharmacy, Mettu University, Mettu, Ethiopia.
J Exp Pharmacol. 2021 Jul 14;13:661-668. doi: 10.2147/JEP.S304933. eCollection 2021.
In the attempt of searching for potential plant derived antimalarial medicines, the aim of the present study was to examine In vivo antimalarial efficacy of crude ethanol extracts of the leaves of and using chloroquine (CQ) sensitive strains of in Swiss albino mice.
To ascertain the safety level of the plant materials, crude extracts underwent oral acute toxicity assessments whereby mice received up to a single dose of 3000 mg/kg. Peter's four day standard antimalarial suppressive test was carried out to determine growth inhibition of parasitemia at tested doses of 400, 600, and 800 mg/kg of the extracts. Survival time of experimental mice and preliminary phytochemical screenings of the extracts were also done according to the standard procedures.
Extracts of the plant materials did not produce severe acute toxic effects in mice that received up to 3000 mg/kg in a single dose. Although complete clearance was not recorded, extracts of the plant materials produced dose dependent suppression of the parasitemia. The highest growth inhibition recorded was by extract of (61.44%) followed by (59.3%) at 800 mg/kg of tested doses. Whereas, complete parasitemia clearance was attributed in mice treated with 25 mg/kg of CQ. In addition, survival time of experimental mice was recorded and the result showed mice treated with the extracts lived longer than the corresponding negative controls. The phytochemical screening of the extracts revealed the presence of antimalarial active constituents such as alkaloids, saponins, cardiac glycosides, flavonoids, terpenoids, steroids, phenols, and tannins.
The present study, therefore, suggests that crude ethanol extracts of , and are safe and rich with active secondary metabolites which have promising antimalarial effects.
为了寻找潜在的植物源抗疟药物,本研究旨在使用瑞士白化小鼠体内对氯喹(CQ)敏感的疟原虫菌株,检测[植物名称1]和[植物名称2]叶片粗乙醇提取物的体内抗疟效果。
为确定植物材料的安全水平,对粗提取物进行口服急性毒性评估,让小鼠接受高达3000毫克/千克的单剂量提取物。采用彼得氏四天标准抗疟抑制试验,以确定在400、600和800毫克/千克测试剂量下提取物对疟原虫血症的生长抑制作用。还按照标准程序记录了实验小鼠的存活时间,并对提取物进行了初步植物化学筛选。
在单剂量接受高达3000毫克/千克提取物的小鼠中,植物材料提取物未产生严重的急性毒性作用。虽然未记录到完全清除疟原虫,但植物材料提取物对疟原虫血症产生了剂量依赖性抑制作用。在800毫克/千克测试剂量下,[植物名称1]提取物的生长抑制率最高(61.44%),其次是[植物名称2]提取物(59.3%)。而在用25毫克/千克氯喹治疗的小鼠中疟原虫血症完全清除。此外,记录了实验小鼠的存活时间,结果显示用提取物治疗的小鼠比相应的阴性对照存活时间更长。提取物的植物化学筛选显示存在抗疟活性成分,如生物碱、皂苷、强心苷、黄酮类、萜类、甾体、酚类和单宁。
因此,本研究表明,[植物名称1]和[植物名称2]的粗乙醇提取物是安全的,富含具有潜在抗疟作用的活性次生代谢产物。